Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Szlovákia

1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Košice, Piešťany

  Életkor

  5 év to 80 év

  People

  1072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970